Surveillance and Characterization of Drug-Resistant Mycobacterium tuberculosis Isolated in a Reference Hospital from Argentina during 8 Years' Period

被引:2
作者
Rocio Imperiale, Belen [1 ]
Beatriz Di Giulio, Angela [2 ]
Belen Mancino, Maria [3 ]
Jose Zumarraga, Martin [4 ]
Susana Morcillo, Nora [3 ]
机构
[1] Consejo Nacl Invest Cient & Tecn, Inst Expt Med, Lab Immunol Resp Dis, Natl Acad Med, Buenos Aires, DF, Argentina
[2] Petrona V de Cordero Hosp, Mycobacteriol Lab, San Fernando, Buenos Aires, Argentina
[3] Dr Cetrangolo Hosp, TB & Mycobacterioses Lab, Vicente Lopez, Argentina
[4] CONICET INTA, Inst Agrobiotechnol & Mol Biol IABIMO, Hurlingham, Buenos Aires, Argentina
关键词
Drug-resistance; genotyping; mutations; tuberculosis; RAPID DETECTION; COMPLEX; ASSAY; TRANSMISSION; CHALLENGES; 1ST;
D O I
10.4103/ijmy.ijmy_94_19
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Argentina is considered a country with a middle tuberculosis (TB) incidence. However, according to the last national epidemiological report released in 2018, since 2013, the trends are steadily increasing. The aims of this study were to determine the drug-resistance (DR), multi-DR and extensively DR (MDR/XDR-TB), and rifampicin resistance (RIF-R) burden as a part of the local TB diagnosis (June 2010-August 2018); to detect the mutations associated to isoniazid (INH) and RIF-R and their geographical distribution; arid to analyze the lineage relationship among the genetic patterns of the isolates circulating in the community. Methods: Respiratory and extrapulmonary specimens were processed by Ziehl-Neelsen stain and cultured on specific media. Drug-susceptibility testing of isolates was performed by the MGIT 960 and a colorimetric micro-method. Mutations conferring DR were detected by Genotype and DNA sequencing. Results: The study showed a DR-TB prevalence of approximately 20% of the isolated strains, while M/XDR-TB-and particularly RIF-R-affected more than 5.0% of the total amount of cases. DR geographical distribution revealed isolates carrying mutations in the inhA gene promoter region only constrained to three districts where it was also registered two same family relatives' cases with the infrequent rpoB 5522 L/Q mutation. The fact that most DR/MDR-TB isolates were not grouped in genetic clusters suggested that these cases may mostly have occurred due to endogenous reactivation rather than recently transmission. Conclusion: According to the obtained results, it would be convenient, in highly MDR-TB suspected individuals, to confirm phenotypically, the INH and RIF susceptibility detected by molecular tests.
引用
收藏
页码:223 / 228
页数:6
相关论文
共 29 条
  • [1] Argentine Association of Respiratory Medicine, 2017, CAS TUB ARG INCR 6 2
  • [2] Dale JW, 2001, INT J TUBERC LUNG D, V5, P216
  • [3] Dickinson B., 1996, BBL MGIT PRODUCTS DE
  • [4] Detection of First- and Second-Line Drug Resistance in Mycobacterium tuberculosis Clinical Isolates by Pyrosequencing
    Engstrom, Anna
    Morcillo, Nora
    Imperiale, Belen
    Hoffner, Sven E.
    Jureen, Pontus
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (06) : 2026 - 2033
  • [5] Multidrug-resistant tuberculosis around the world: what progress has been made?
    Falzon, Dennis
    Mirzayev, Fuad
    Wares, Fraser
    Baena, Ines Garcia
    Zignol, Matteo
    Nguyen Linh
    Weyer, Karin
    Jaramillo, Ernesto
    Floyd, Katherine
    Raviglione, Mario
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (01) : 150 - 160
  • [6] PHYLOViZ: phylogenetic inference and data visualization for sequence based typing methods
    Francisco, Alexandre P.
    Vaz, Catia
    Monteiro, Pedro T.
    Melo-Cristino, Jose
    Ramirez, Mario
    Carrico, Joao A.
    [J]. BMC BIOINFORMATICS, 2012, 13
  • [7] Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria
    Hanna, BA
    Ebrahimzadeh, A
    Elliott, LB
    Morgan, MA
    Novak, SM
    Rusch-Gerdes, S
    Acio, M
    Dunbar, DF
    Holmes, TM
    Rexer, CH
    Savthyakumar, C
    Vannier, AM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (03) : 748 - 752
  • [8] What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi-and Extensively Drug-Resistant Tuberculosis
    Heyckendorf, Jan
    Andres, Soenke
    Koser, Claudio U.
    Olaru, Ioana D.
    Schon, Thomas
    Sturegard, Erik
    Beckert, Patrick
    Schleusener, Viola
    Kohl, Thomas A.
    Hillemann, Doris
    Moradigaravand, Danesh
    Parkhill, Julian
    Peacock, Sharon J.
    Niemann, Stefan
    Lange, Christoph
    Merker, Matthias
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (02)
  • [9] Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs
    Imperiale, B. R.
    Zumarraga, M. J.
    Di Giulio, A. B.
    Cataldi, A. A.
    Morcillo, N. S.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (08) : 1088 - 1093
  • [10] Rapid detection of multidrug-resistant Mycobacterium tuberculosis by multiplex allele-specific polymerase chain reaction
    Imperiale, B. R.
    Cataldi, A. A.
    Morcillo, N. S.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2011, 15 (04) : 496 - 501